The performance characteristics of the Verigene Gram-positive blood culture (BC-GP) assay were evaluated in pediatric patients. Concordance of the BC-GP assay was 95.8%, with significant decreases in turnaround time for identification and resistance detection. BC-GP is highly accurate and can be integrated into the routine workflow of the microbiology laboratory.
Bloodstream infections are one of the leading causes of death in the United States, and prompt initiation of appropriate antimicrobial therapy is essential to significantly improve patient management and reduce the rate of mortality of bacteremic patients (1). Gram-positive pathogens are implicated in Ͼ50% of all bacterial bloodstream infections, with coagulase-negative staphylococci (CoNS) being the most common Gram-positive bacteria isolated from blood culture, followed by Staphylococcus aureus and Enterococcus spp. (2-4). Similar findings have been demonstrated in our institution where approximately 64% of all positive blood cultures consist of Gram-positive organisms. The workup of pathogens in the clinical microbiology laboratory is a key contributing factor in overall mortality rate, as delays in identification and susceptibility testing have been demonstrated to directly impact patient survival (5). Previous studies have been fundamental in directly correlating rapid identification of Gram-positive pathogens with improved patient outcome, decreased hospital length of stay, and decreased hospital costs (6-9). Moreover, direct detection of the mecA gene in methicillin-resistant S. aureus (MRSA) has been demonstrated to be an effective tool for managing vancomycin usage as well as reducing both hospital length of stay and costs (10, 11).The Verigene Gram-positive blood culture (BC-GP) assay (Nanosphere Inc., Northbrook, IL) is a microarray-based, multiplexed, molecular assay approved by the Food and Drug Administration (FDA) for rapid detection and identification of 12 Gram-positive targets (S. aureus, Staphylococcus epidermidis, Staphylococcus lugdunensis, Staphylococcus spp., Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus anginosus group, Streptococcus pneumoniae, Streptococcus spp., Enterococcus faecium, Enterococcus faecalis, Listeria monocytogenes) and 3 resistance markers (mecA, vanA, vanB). Four recent studies have evaluated the performance of the BC-GP assay on different bottle types (12-15). Specifically, Sullivan et al. reported high sensitivity and specificity in pediatric patients using BacT/Alert pediatric FAN (PF) blood cultures (14). This study evaluated the performance characteristics of the BacT/Alert standard aerobic (SA) noncharcoal and PF charcoal blood culture bottles collected from pediatric patients admitted to Children's Hospital Los Angeles (CHLA), a freestanding pediatric tertiary care center. The implementation process and comparison of workflow and turnaround time (TAT) were also assessed. A total of 203 positive blood cultures (104 SA, 99 PF) from 203 pediatric patients submitted for routine workup to th...